Cargando…

Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease

BACKGROUND: Endoscopic recurrence is common in postoperative patients with Crohn’s disease (CD). Monitoring endoscopic recurrence is important for selecting an appropriate treatment to prevent the development of postoperative disease. The aim of this study was to develop and validate a diagnostic mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Gaoshi, Chen, Rirong, Jiang, Yueyun, Li, Li, Zheng, Jieqi, Li, Chao, Zhang, Shenghong, Chen, Minhu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984852/ https://www.ncbi.nlm.nih.gov/pubmed/35399190 http://dx.doi.org/10.1177/17562848221089096

Ejemplares similares

Prognostic models for predicting postoperative recurrence in Crohn’s disease: a systematic review and critical appraisal
por: Chen, Rirong, et al.
Publicado: (2023)

A Novel Model Based on Serum Biomarkers to Predict Primary Non-Response to Infliximab in Crohn’s Disease
por: Li, Li, et al.
Publicado: (2021)

Prealbumin and Retinol-Binding Protein 4: The Promising Inflammatory Biomarkers for Identifying Endoscopic Remission in Crohn’s Disease
por: Chen, Rirong, et al.
Publicado: (2021)

Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn’s disease patients with isolated anastomotic lesions
por: Chen, Rirong, et al.
Publicado: (2023)

Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease
por: Chen, Rirong, et al.
Publicado: (2020)

Metabolomics facilitate the personalized management in inflammatory bowel disease
por: Chen, Rirong, et al.
Publicado: (2021)

Serum amyloid protein A in inflammatory bowel disease: from bench to bedside
por: Chen, Rirong, et al.
Publicado: (2023)

Serum exosomal microRNA-144-3p: a promising biomarker for monitoring Crohn's disease
por: Chen, Peng, et al.
Publicado: (2021)

Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020)

Hypermethylation of miR-145 promoter-mediated SOX9-CLDN8 pathway regulates intestinal mucosal barrier in Crohn's disease
por: Zhuang, Xiaojun, et al.
Publicado: (2022)

Trajectory of fecal lactoferrin for predicting prognosis in ulcerative colitis
por: Chen, Rirong, et al.
Publicado: (2023)

Protocadherin 20 maintains intestinal barrier function to protect against Crohn’s disease by targeting ATF6
por: Huang, Shanshan, et al.
Publicado: (2023)

Ubiquitin-specific proteases in inflammatory bowel disease-related signalling pathway regulation
por: Chen, Rirong, et al.
Publicado: (2022)

Current insights on the roles of gut microbiota in inflammatory bowel disease-associated extra-intestinal manifestations: pathophysiology and therapeutic targets
por: Tie, Yizhe, et al.
Publicado: (2023)

Fecal lactoferrin early predicts long‐term outcomes in ulcerative colitis: A post‐hoc analysis of the UNIFI and PURSUIT trials
por: Chen, Rirong, et al.
Publicado: (2023)

Tripartite motif family proteins in inflammatory bowel disease: Mechanisms and potential for interventions
por: Chen, Rirong, et al.
Publicado: (2022)

Multi-Omics Analysis of Western-style Diet Increased Susceptibility to Experimental Colitis in Mice
por: Lin, Lihui, et al.
Publicado: (2022)

Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
por: Lin, Lihui, et al.
Publicado: (2020)

Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease
por: Xie, Zhuo, et al.
Publicado: (2021)

Mucosal Healing Is Associated With the Reduced Disabling Disease in Crohn's Disease
por: Huang, Shanshan, et al.
Publicado: (2019)

Thalidomide Combined With Azathioprine as Induction and Maintenance Therapy for Azathioprine-Refractory Crohn's Disease Patients
por: Li, Tong, et al.
Publicado: (2020)

A New Model Based on 25-Hydroxyvitamin D3 for Predicting Active Crohn's Disease in Chinese Patients
por: Lin, Sinan, et al.
Publicado: (2018)

Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqin, et al.
Publicado: (2020)

A Novel Nomogram Combining Mucus Barrier Index for Predicting Treatment Failures in Ulcerative Colitis
por: Wang, Ying, et al.
Publicado: (2023)

Correction to: Normalization of C-Reactive Protein Predicts Better Outcome in Patients With Crohn's Disease With Mucosal Healing and Deep Remission
por: Lin, Xiaoqing, et al.
Publicado: (2020)

Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn’s disease
por: Zhou, Longyuan, et al.
Publicado: (2023)

Strategies for Preventing Endoscopic Recurrence of Crohn's Disease 1 Year after Surgery: A Network Meta-Analysis
por: Feng, Jin-shan, et al.
Publicado: (2017)

Risk Factors Associated with Impaired Ovarian Reserve in Young Women of Reproductive Age with Crohn’s Disease
por: Zhao, Yue, et al.
Publicado: (2020)

Insights into the molecular mechanisms and therapeutic implications of interleukin-6 for inflammatory bowel disease
por: Tie, Yizhe, et al.
Publicado: (2023)

Circulating MicroRNA223 is a New Biomarker for Inflammatory Bowel Disease
por: Wang, Huiling, et al.
Publicado: (2016)

Clinical and Endoscopic Recurrence after Surgical Resection in Patients with Crohn's Disease
por: Lee, Yang Woon, et al.
Publicado: (2014)

Can fecal calprotectin accurately identify histological activity of ulcerative colitis? A meta-analysis
por: Ye, Xiaoqi, et al.
Publicado: (2021)

Identifying immune cell infiltration and effective diagnostic biomarkers in Crohn’s disease by bioinformatics analysis
por: Huang, Rong, et al.
Publicado: (2023)

Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn’s disease
por: Holmer, Ariela K., et al.
Publicado: (2020)

Early Postoperative Endoscopic Recurrence in Crohn’s Disease Is Characterised by Distinct Microbiota Recolonisation
por: Machiels, Kathleen, et al.
Publicado: (2020)

Serum adipokines as non-invasive biomarkers in Crohn’s disease
por: Ortega Moreno, Lorena, et al.
Publicado: (2020)

Non-invasive Serological Monitoring for Crohn’s Disease Postoperative Recurrence
por: Hamilton, Amy L, et al.
Publicado: (2022)

Oxidative stress gene expression, DNA methylation, and gut microbiota interaction trigger Crohn’s disease: a multi-omics Mendelian randomization study
por: Xu, Shu, et al.
Publicado: (2023)

Identification and validation of the common pathogenesis and hub biomarkers in Hirschsprung disease complicated with Crohn’s disease
por: Wang, Jing, et al.
Publicado: (2022)

Enterohepatic Helicobacter Species as a Potential Causative Factor in Inflammatory Bowel Disease: A Meta-Analysis
por: Yu, Qiao, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_eu0rqoiu3dg1ppb1tsc87g1rdg